Overview

A Study of KHK4827 in Subjects With Palmoplantar Pustulosis

Status:
Active, not recruiting
Trial end date:
2022-10-01
Target enrollment:
Participant gender:
Summary
Evaluation of efficacy and safety of KHK4827 in Subjects with Palmoplantar Pustulosis
Phase:
Phase 3
Details
Lead Sponsor:
Kyowa Kirin Co., Ltd.
Treatments:
Brodalumab